A feasibility study of gemcitabine, S-1 and leucovorin combination therapy (GSL) for advanced biliary tract cancer.
Conclusions: This study showed the feasibility and potential efficacy of GSL as a first-line treatment in patients with advanced BTC.
PMID: 31179889 [PubMed - as supplied by publisher]
Source: Journal of Chemotherapy - Category: Cancer & Oncology Tags: J Chemother Source Type: research
More News: Anemia | Anorexia | Cancer | Cancer & Oncology | Chemotherapy | Diarrhoea | Eating Disorders & Weight Management | Gallbladder Cancer | Oral Cancer | Study | Toxicology